Mackenzie Financial Corp Has $177.42 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mackenzie Financial Corp boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 339,906 shares of the medical equipment provider's stock after purchasing an additional 54,234 shares during the period. Mackenzie Financial Corp owned about 0.10% of Intuitive Surgical worth $177,417,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Bennett Selby Investments LP lifted its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 17 shares during the last quarter. Onefund LLC raised its stake in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after purchasing an additional 18 shares in the last quarter. Wesbanco Bank Inc. raised its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after acquiring an additional 19 shares in the last quarter. FSM Wealth Advisors LLC increased its position in Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after buying an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC increased its position in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after buying an additional 19 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company's stock, valued at $2,793,033.06. This represents a 60.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now directly owns 473 shares of the company's stock, valued at $271,397.94. This represents a 63.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock worth $16,865,621 over the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 2.0%

NASDAQ ISRG traded up $10.65 on Tuesday, reaching $550.19. The company had a trading volume of 1,243,739 shares, compared to its average volume of 1,645,228. The stock's 50 day moving average is $512.50 and its 200-day moving average is $538.12. The stock has a market cap of $197.20 billion, a price-to-earnings ratio of 85.83, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52 week low of $396.15 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the company earned $1.50 earnings per share. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently commented on ISRG shares. Evercore ISI decreased their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Barclays reduced their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Finally, Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.